On Tuesday, Sen. Elizabeth Warren (D-Mass.) slammed Meta Platforms, Inc.'s META alleged tax windfalls under President Donald Trump's new legislative package, saying the benefits far outweigh what ordinary Americans could ever contribute.
What Happened: Warren criticized a provision in Trump's "Big Beautiful Bill" that she says offers Meta a massive tax break.
"If every one of the 340 million people in America paid a new $35 copay to visit the doctor, that still wouldn't be enough to cover how much Meta would get from just one tax break in Donald Trump’s ‘Big Beautiful Bill,'" she posted on X, formerly Twitter.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — this is your last chance to become an investor for $0.80 per share.
The U.S. population is estimated at 342 million, according to the Census — a number that, as Warren pointed out, wouldn’t be enough to offset the tax break given to Mark Zuckerberg’s company under the “Big Beautiful Bill.”
Warren and Meta did not immediately respond to Benzinga's request for comments.
See Also: Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can invest with $1,000 at just $0.30/share.
Why It's Important: Earlier this month, Warren slammed the "One Big Beautiful Bill Act," warning it could cause 16 million Americans to lose health coverage and add $2.4 trillion to the national debt.
Citing Congressional Budget Office estimates, Warren said the bill disproportionately benefits billionaires like Jeff Bezos and Mark Zuckerberg at the expense of everyday Americans.
Warren has also opposed a provision in the bill that would prevent states from regulating artificial intelligence for 10 years. She argued this could lead to higher rents by protecting companies like RealPage. Representative Marjorie Taylor Greene has also criticized the measure.
Bezos and Zuckerberg's Meta have each contributed $1 million to Trump's Jan. 20 inauguration.
Read Next:
- Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Back a bold new approach to cancer treatment with high-growth potential.
- These five entrepreneurs are worth $223 billion – they all believe in one platform that offers a 7-9% target yield with monthly dividends
Photo courtesy: Sheila Fitzgerald / Shutterstock.com
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.